Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
We propose to study the effects of Physician Orders for Scope of Treatment (POST) Facilitation in a randomized controlled trial in a population of community dwelling older adults who qualify for POLST facilitation, including those with normal cognition and those with Alzheimer's Disease and Related Disorders.
Full description
The POLST paradigm, which stands for Physician Orders for Life Sustaining Treatment, was developed to address inconsistencies between care received and patient and family wishes for treatment, with an aim to increase concordant care. The POLST paradigm is nationally recognized and implemented in a number of states under different names. In Indiana, for example, it is called "Physician Orders for Scope of Treatment" (POST). Because of this, all patient facing materials will refer to POST, however, we use the terms POST and POLST interchangeably in this proposal.
POLST affects delivery of medical interventions and improved concordance between patient preferences and care received.
Our specific aims are:
To test the effect of high quality POLST Facilitation delivered in the home compared to attention control on:
a.discordance between preferences for treatment and treatments received in the subsequent 12 months (primary outcome).
To test the effect of POLST Facilitation on intermediate outcomes including:
To test the effect of a POLST Facilitation on secondary outcomes of cost and end-of-life care including:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients:
65 or older
have decision making capacity OR a qualified surrogate decision maker
must meet one of the following index scores:
must be able to pass consent verification
must not be enrolled in hospice
must not have an acute illness
must give patient's provider opportunity to review the "surprise question" (e.g. would you be surprised if the patient died in the next year) to confirm anticipated mortality within the next year (14 days to respond)
must not have a POST form on file.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
389 participants in 2 patient groups
Loading...
Central trial contact
Emily S Burke, BA; Alexia M Torke, MD, MS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal